The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 2.5 mg tablets. The contract, valued at $4,453.50, has a period of performance through November 20, 2024. This award is under DLA's ECAT Generation V Program, a large indefinite delivery contract (IDC) valued at $999,999,999.00 that enables Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract is not designated as a set-aside.
Generated 2/18/25, 1:45 PM